Search Results 591-600 of 13500 for monoclonal antibody

1. Dendritic Cell Therapy, Cryosurgery, And Pembrolizumab In Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

   Cryosurgery kills cancer cells by freezing them. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

2. Talquetamab-tgvs (subcutaneous route) - Side effects & uses - Mayo Clinic

   These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

3. Medical Research & Education - Mayo Clinic News Network

   Monoclonal antibodies help COVID-19 patients avoid hospitalization featured image. COVID-19. Monoclonal antibodies help COVID-19 patients avoid hospitalization.

4. Testing The Addition Of The Drug Atezolizumab To The Usual Radiation Treatment For Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

5. Pembrolizumab And Binimetinib In Treating Patients With Locally Advanced Or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may block tumor growth in ... Prior anti-cancer therapy with a monoclonal antibody (mAb) =< 4 weeks prior ...

6. Isatuximab In Treating Patients With Relapsed Or Refractory Primary Amyloidosis - Mayo Clinic

   Monoclonal antibodies, such as isatuximab, may ... Patients must not have any known allergies to isatuximab or other monoclonal antibody therapies.

7. Merkel Cell Carcinoma Clinical Trials - Mayo Clinic Research

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

8. A Study To Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) For Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

9. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

10. Oncology (Medical) - Clinical trials

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...